Amai Proteins logo — Curing the food system one protein at a time. 1st product is...

Amai Proteins

Curing the food system one protein at a time. 1st product is a sugar substitute that is a sustainable, healthy & tasty.

Founded 2016 Israel Israel 51 employees Series Unknown Total: $13.72M Biotechnology, Food and Beverage

General Information

Company Name Amai Proteins
Founded Year 2016
Location Israel Israel +1
Employees 51
Industries Biotechnology, Food and Beverage
Funding Stage Series Unknown
Social

Get notified when Amai Proteins moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

Recorded by Bounce Watch from public sources. Every entry below carries the date we observed it, and when we have not looked recently the page says so rather than leaving silence to imply nothing happened.

Key Hire Sep 03, 2026

Amai Proteins has appointed Doug Brown as its new CEO, effective September 1st, 2026. He brings decades of experience from companies like Sirio Pharma and Best Formulations.

Regulatory Approval Aug 31, 2026

Amai Proteins' sweelin® sweet protein has received official approval from the Israeli Ministry of Health as a novel food ingredient.

Market Expansion Aug 31, 2026

Amai Proteins announced market entry into Israel, United States, and Singapore with sweelin®, following three regulatory approvals.

About Amai Proteins

Amai Proteins, founded in 2016 and headquartered in Israel, is a cutting-edge player in the Biotechnology and Food and Beverage industries. The firm has made significant strides by leveraging a novel approach to developing proteins that cater to both consumer preferences and industry demands.

The company's flagship product is a sweet protein, a sustainable and healthy sugar substitute derived from a natural fermentation process. This innovation reflects its slogan: "Curing the food system one protein at a time." Through its pro-protein platform, Amai Proteins is poised to influence the future landscape of protein application significantly.

The company's most recent financial milestone was a Venture Round investment concluded on 04 December 2022. Though specific investors in this round are unnamed, the investment underscores the confidence in Amai Proteins as a leader in pioneering sustainable, health-focused food solutions.

Taxonomy: Sweet Protein, Sugar Substitute, Sustainable Ingredients, Fermentation Technology, Protein Design, Agile Integrative Computational Protein Design, Healthy Ingredients, Food Innovation, Food and Beverage Industry, Protein Engineering, Natural Fermentation, Equatorial Belt Proteins, Designer Proteins, Future of Proteins

Services & Products

Development of Designer Proteins
Sugar Reduction in Foods
AI-Driven Protein Design
Precision Fermentation

Target Customers

Food and Beverage Manufacturers Health-conscious Consumers Sustainable Product Developers Nutritional Product Innovators

Funding Rounds & Investors (7)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round •••••• - 04 Dec 2022
Venture Round •••••• 5
Investor Investor Investor
•••• ••••
01 Jul 2021
Seed Round •••••• 2
Investor
•••• ••••
30 Apr 2020
Series A •••••• 7
Investor Investor Investor Investor Investor Investor Investor
06 Apr 2020
Seed Round •••••• 1
Investor
01 Jun 2019

View All 7 Funding Rounds

Amai Proteins Alternatives & Competitors

View All Alternatives
Amai Proteins vs
Profluent
Profluent United States

Grounded in nature, authored by AI

Series Unknown
69 employees
AI, Biotechnology
Amai Proteins vs
Adaptyv
Adaptyv Switzerland

The cloud lab for protein designers

Series A
36 employees
Biotechnology, Pharmaceutical
Amai Proteins vs

From Topology to Treatments.

Unknown
44 employees
Biotechnology, Pharmaceutical

FAQ About Amai Proteins

Curing the food system one protein at a time. 1st product is a sugar substitute that is a sustainable, healthy & tasty.
Amai Proteins was founded in 2016.
Amai Proteins is headquartered in Israel.
Amai Proteins operates in the following industries: Biotechnology, Food and Beverage.
Amai Proteins has approximately 51 employees.
Amai Proteins has completed 7 funding rounds, raising a total of $13.72M. The latest funding stage is Series Unknown.
Amai Proteins offers: Development of Designer Proteins, Sugar Reduction in Foods, AI-Driven Protein Design, Precision Fermentation.
Top alternatives and competitors to Amai Proteins include Profluent, Adaptyv, Congruence Therapeutics, Magnet Biomedicine, Bio-Prodict. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Amai Proteins and Profluent are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Amai Proteins and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy